Patent-Pending Physician-Founded

90% of CPR Fails.
We're Fixing That.

OptiCPR uses AI to show exactly where to push during CPR—personalized for each patient.
One pad. One light. Zero guesswork.

0 Annual Cardiac Arrests
in North America
<8% Survival with Good
Neurologic Outcomes
40-100% CPR Compressions
Suboptimally Placed
Get Involved See How It Works
The Problem

Every Second Counts.
Every Centimeter Matters.

LV Standard CPR Guidelines
Actual heart position (varies by patient)
Standard Guidelines: Fixed "Lower Sternum"

Despite decades of CPR training, a critical flaw persists in cardiac arrest response.

40-100%

of chest compressions miss the optimal location (the left ventricle position varies significantly between patients)

1 in 2

Compressions don't increase perfusion because they're applied to the wrong location relative to the heart

The Current "Gold Standard" Is Impractical

Transesophageal echocardiography (TEE) can identify optimal compression location, but requires:

  • ✕ Invasive esophageal probe insertion
  • ✕ Specialized physician training
  • ✕ Expensive equipment ($50,000+)
  • ✕ Extremely impractical in pre-hospital settings
The Solution

OptiCPR: A Smart Patch That
Shows Where to Push

1

Stick the patch on the chest

Just like a defibrillator pad

2

AI maps the heart in seconds

Using electrical signals from 16 electrodes

3

LED lights up the exact spot

Push here. No guessing. No training needed.

Non-invasive
Works pre-hospital
No special training
Integrates with AEDs

Why OptiCPR Wins

Traditional CPR
TEE-Guided
OptiCPR
Non-Invasive
✓
✕
✓
Personalized
✕
✓
✓
Pre-Hospital
✓
✕
✓
No Training
✓
✕
✓
Cost per Use
~$0
$500+
~$50

Why Now?

AI Maturity

Signal processing algorithms finally powerful enough to analyze cardiac electrical activity in real-time

Research Proof

Studies now confirm what physicians suspected: personalized compression location dramatically improves outcomes

Traction & Validation

Already Making
Real Progress

$387K Non-Dilutive Grants Secured
MITACS MedTeQ+
100% Pre-Clinical Success Identified optimal compression site in all subjects
1 Patent Filed US 18/972,066 (Dec 2024)
In Production First Pads Hardware manufacturing underway
Pre-Clinical Validation
VALIDATED
100% Success Rate
Identified 1st or 2nd optimal compression site in every subject
Validated by coronary perfusion pressure (gold standard)
From 16 possible positions - consistently accurate

Development Roadmap

2023-2024

Research & IP

Proof-of-concept validation, provisional patent

2024-2025

Patent & Grants

Full patent filed, $387K in grants secured

2025-2026

Prototype Development

Working prototype, pre-clinical validation

2026-2027

Clinical Trials

Human trials, regulatory submission

2027-2028

Commercial Launch

Health Canada/FDA approval, market entry

Research Partners

Urgences-santé Quebec's largest EMS provider
Concordia University Research collaboration
Total Invested to Date $927K+
$387K Grants
$40K Cash
$500K+ Founder Time

Join Our Pre-Seed Round

Structure SAFE Note
Terms Flexible for early supporters
Minimum No minimum - all believers welcome
Request Investor Deck

Other Ways to Support

Research Donation Support our mission to save lives
Strategic Partnership EMS, hospitals, device manufacturers
Foundation Grant Heart health & medical research foundations

Equity crowdfunding campaign coming soon

Leadership

Built by Experts
Who Understand the Problem

LL

Dr. Lawrence Leroux, MD

Chief Scientific Officer & Co-Founder

Anesthesiologist and researcher at Université de Montréal. Prior experience in emergency medicine and critical care. Co-founder of a prehospital ECMO research program. Currently pursuing a Master's degree developing AI models for real-time cardiac arrest management.

RL

Richard Laberge

President & Co-Founder

Seasoned technology executive with decades of experience scaling innovative companies. Former VP of Business Development at D-BOX Technologies and co-founder of Sensio. Leading IMPACK-CPR's commercialization strategy and business operations.

LPF

Dr. Louis-Philippe Fortier, MD, MSc

Chief Medical Officer & Co-Founder

Senior Anesthesiologist and Surgical/Perioperative Activities Medical Coordinator. Co-inventor of the LT10G Surgical Magnetic Mat, bringing proven medical device innovation experience to IMPACK-CPR.

EF

Étienne Fortin

Chief Technology Officer & Co-Founder

Principal Director of Cloud Deployment Program at National Bank of Canada. Enterprise-scale technology expertise ensuring IMPACK-CPR's devices meet the highest standards for reliability, security, and regulatory compliance.

FL

François Laberge

AI & Software Developer & Co-Founder

Leading the development of IMPACK-CPR's proprietary AI algorithms and signal processing software. Building the intelligent systems that power real-time cardiac mapping and compression guidance.

Imagine a World Where Every Cardiac Arrest Patient
Receives Personalized, Optimal CPR

IMPACK-CPR is pioneering the era of precision resuscitation, where AI-guided technology ensures that every compression is optimally placed, every defibrillation is precisely targeted, and every patient has the best possible chance of survival.

2x Potential Survival Rate Improvement
45,000+ Additional Lives Saved Annually (North America)

"If it's worth doing, it's got to be done now."

— Dr. Peter Safar, Father of CPR
Latest Science

Resuscitation Research
Feed

Staying at the forefront of cardiac arrest science

Loading latest research...

View More Research on PubMed →
Get Involved

Join Us in Revolutionizing
Cardiac Arrest Survival

We're seeking strategic investors who share our vision of saving lives through precision medicine and disruptive medical technology.

richard.laberge@impackcpr.com
Montreal, Quebec, Canada
Richard Laberge
President, IMPACK-CPR